Medicine Overview of Olmetrack CT Tablet
Nausea, Altered taste, Diarrhoea, Stomach upset, Weakness, Headache, Dizziness, Increased blood uric acid, Increased blood lipid level, Electrolyte imbalance, Glucose intolerance, Decreased blood pressure.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Olmetrack CT 20 mg/12.5 mg Tablet is to be taken with food.
Olmetrack CT 20 mg/12.5 mg Tablet is a combination of two medicines: Olmesartan and chlorthalidone which lower blood pressure effectively. Olmesartan is an angiotensin receptor blocker (ARB). It works by blocking the hormone angiotensin thereby relaxing blood vessels. This allows the blood to flow more smoothly and the heart to pump more efficiently. Chlorthalidone is a diuretic that removes extra water and certain electrolytes from the body. Over time it also relaxes blood vessels and improves blood flow.
In Depth Information on Olmetrack CT Tablet
Olmetrack CT Tablet related warnings
Taking Chlorthalidone with alcohol may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.
WEIGH RISKS VS BENEFITS
Olmetrack CT 20 mg/12.5 mg Tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Olmetrack CT 20 mg/12.5 mg Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Olmetrack CT 20 mg/12.5 mg Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Olmetrack CT 20 mg/12.5 mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Olmetrack CT 20 mg/12.5 mg Tablet may be needed. Please consult your doctor.
Use of Olmetrack CT 20 mg/12.5 mg Tablet is not recommended in these patients.
Olmetrack CT 20 mg/12.5 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Olmetrack CT 20 mg/12.5 mg Tablet may be needed. Please consult your doctor.
Use of Olmetrack CT 20 mg/12.5 mg Tablet is not recommended in patients with severe liver disease.
No Patient Concerns found for this medicine
User Submitted Feedback For Olmetrack CT 20 mg/12.5 mg Tablet
Patients taking Olmetrack CT 20 mg/12.5 mg Tablet What were the side-effects while using Olmetrack CT 20 mg/12.5 mg Tablet? How do you take Olmetrack CT Tablet? How much was the improvement? Please rate Olmetrack CT 20 mg/12.5 mg Tablet on price What are you using Olmetrack CT Tablet for?
Survey Participants: 8
“The following are the results of on-going survey on 1mg.com for Olmetrack CT 20 mg/12.5 mg Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
One of the following vendor pharmacies will deliver Olmetrack CT 20 mg/12.5 mg Tablet: MDH, TFP, DGN, NNH, BIO, OLT, MPC, MAK, RJH, JVO, PLT, JVN, RSS, RWP, ATL, BHM, BMJ, UMP, WHL, OIP, HGI, AGT, SVH, NWP, DVH, RPI, ARD, PWN, DPP, ZVP, HSP, NSL, TNH, BTM, BBS, SLN, SRG, AMR, JSL, HBV, VNS, IAD, HIP, LHA, PRN, SBA, INC, SGH, SHP, VRS, BSN, WSI, AAY, ZEL, MAM, CLT, AYM, EQN, NTB, ENP, GHR, SDM, ABP, SPD, HNP, P2P, BHP, RDH, KHH, MAX, KMC, OWP, HEX, DHR, BLE, GNC, PPR, NXG, GPP, RUS, OHM, BDN, PMA, SBL, FGH, DLP, RSA, RKS, IPL, GPT, VDH, CHP, USF, DFP, TOM, SGC, LCC, GTK, ADT, GTC, HTS, SJP, AYU, RHL, SWP, GBL, SWA, RPP, BAL, SSA, HAT, SCH, ESY, ANT, RHW, PNT, NVL, NVY, PEN, PVP, JIV, QLF, ATP, DPL, SHC, SHD, KHC, TRP, NAS, NDP, HZF, MLC, MMS, MDO, 9T9, EPS, HMP, PTI, ZPR, RDR, EVP, DAO, SVS, HPC, THP, DYG, QTM, SYN, EMB, MSD, AAR, SAF, STA, BAP